Systemic carboplatin for retinoblastoma: change in tumour size over time

Background/aim: Chemotherapy for intraocular retinoblastoma is used to shrink individual retinal tumours to a size amenable to focal treatments. Quantitative data regarding retinal tumour response following treatment with primary systemic carboplatin are reported. Methods: Changes in area and larges...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Abramson, D H, Lawrence, S D, Beaverson, K L, Lee, T C, Rollins, I S, Dunkel, I J
Médium: Artigo
Jazyk:Inglês
Vydáno: Copyright 2005 British Journal of Ophthalmology 2005
Témata:
Clinical Science - Extended Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1772963/
https://ncbi.nlm.nih.gov/pubmed/16299142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2005.072033
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky